Statins reduce endothelial cell apoptosis via inhibition of TRAIL expression on activated CD4 T cells in acute coronary syndrome

Atherosclerosis

Volumn 213, Issue 1, 2010, Pages 33-39

  Sato, Kayoko ^a   Nuki, Toshiyuki ^a   Gomita, Keiko ^a   Weyand, Cornelia M ^b   Hagiwara, Nobuhisa ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Apoptosis; Atherosclerosis; Endothelium; Inflammation; Lymphocyte; Plaque; Statin

Indexed keywords

CD69 ANTIGEN; COMPLEMENTARY DNA; FLUINDOSTATIN; GUANOSINE TRIPHOSPHATASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN G; MITOGEN ACTIVATED PROTEIN KINASE; PITAVASTATIN; RNA; ROSUVASTATIN; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME ACTIVATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

ACUTE CORONARY SYNDROME; AGED; APOPTOSIS; ATHEROSCLEROSIS; CD4-POSITIVE T-LYMPHOCYTES; ENDOTHELIAL CELLS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INFLAMMATION; MALE; MIDDLE AGED; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 77958474970     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.03.034     Document Type: Article

References (28)

1. van der Wal A.C., Becker A.E., van der Loos C.M., Das P.K. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994, 89:36-44.
2. Kolodgie F.D., Burke A.P., Farb A., et al. The thin-cap fibroatheroma: a type of vulnerable plaque: the major precursor lesion to acute coronary syndromes. Curr Opin Cardiol 2001, 16:285-292.
3. Virmani R., Burke A.P., Farb A., Kolodgie F.D. Pathology of the vulnerable plaque. J Am Coll Cardiol 2006, 47:C13-C18.
4. Nakajima T., Schulte S., Warrington K.J., et al. T-cell-mediated lysis of endothelial cells in acute coronary syndromes. Circulation 2002, 105:570-575.
5. Wiley S.R., Schooley K., Smolak P.J., et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 1995, 3:673-682.
6. Schneider P., Thome M., Burns K., et al. TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB. Immunity 1997, 7:831-836.
7. Pryshchep S., Sato K., Goronzy J.J., Weyand C.M. T cell recognition and killing of vascular smooth muscle cells in acute coronary syndrome. Circ Res 2006, 98:1168-1176.
8. Sato K., Niessner A., Kopecky S.L., et al. T cells induce apoptosis of vascular smooth muscle cells in the atherosclerotic plaque. J Exp Med 2006, 203:239-250.
9. Niessner A., Sato K., Chaikof E.L., et al. Pathogen-sensing plasmacytoid dendritic cells stimulate cytotoxic T-cell function in the atherosclerotic plaque through interferon-alpha. Circulation 2006, 114:2482-2489.
10. Kwak B., Mulhaupt F., Myit S., Mach F. Statins as a newly recognized type of immunomodulator. Nat Med 2000, 6:1399-1402.
11. Rezaie-Majd A., Prager G.W., Bucek R.A., et al. Simvastatin reduces the expression of adhesion molecules in circulating monocytes from hypercholesterolemic patients. Arterioscler Thromb Vasc Biol 2003, 23:397-403.
12. Eccles K.A., Sowden H., Porter K.E., et al. Simvastatin alters human endothelial cell adhesion molecule expression and inhibits leukocyte adhesion under flow. Atherosclerosis 2008, 200:69-79.
13. Villalba M., Hernandez J., Deckert M., Tanaka Y., Altman A. Vav modulation of the Ras/MEK/ERK signaling pathway plays a role in NFAT activation and CD69 up-regulation. Eur J Immunol 2000, 30:1587-1596.
14. Hansson G.K., Holm J., Jonasson L. Detection of activated T lymphocytes in the human atherosclerotic plaque. Am J Pathol 1989, 135:169-175.
15. Zhou X., Stemme S., Hansson G.K. Evidence for a local immune response in atherosclerosis. CD4+ T cells infiltrate lesions of apolipoprotein-E-deficient mice. Am J Pathol 1996, 149:359-366.
16. Durand E., Scoazec A., Lafont A., et al. In vivo induction of endothelial apoptosis leads to vessel thrombosis and endothelial denudation: a clue to the understanding of the mechanisms of thrombotic plaque erosion. Circulation 2004, 109:2503-2506.
17. Youssef S., Stuve O., Patarroyo J.C., et al. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature 2002, 420:78-84.
18. Hakamada-Taguchi R., Uehara Y., Kuribayashi K., et al. Inhibition of hydroxymethylglutaryl-coenzyme a reductase reduces Th1 development and promotes Th2 development. Circ Res 2003, 93:948-956.
19. Link A., Ayadhi T., Bohm M., Nickenig G. Rapid immunomodulation by rosuvastatin in patients with acute coronary syndrome. Eur Heart J 2006, 27:2945-2955.
20. Dunn S.E., Youssef S., Goldstein M.J., et al. Isoprenoids determine Th1/Th2 fate in pathogenic T cells, providing a mechanism of modulation of autoimmunity by atorvastatin. J Exp Med 2006, 203:401-412.
21. Kayagaki N., Yamaguchi N., Nakayama M., et al. Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: a novel mechanism for the antitumor effects of type I IFNs. J Exp Med 1999, 189:1451-1460.
22. Palinski W., Tangirala R.K., Miller E., Young S.G., Witztum J.L. Increased autoantibody titers against epitopes of oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis. Arterioscler Thromb Vasc Biol 1995, 15:1569-1576.
23. Stemme S., Faber B., Holm J., et al. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl Acad Sci USA 1995, 92:3893-3897.
24. Zal B., Kaski J.C., Arno G., et al. Heat-shock protein 60-reactive CD4+CD28 null T cells in patients with acute coronary syndromes. Circulation 2004, 109:1230-1235.
25. Zha Y., Marks R., Ho A.W., et al. T cell anergy is reversed by active Ras and is regulated by diacylglycerol kinase-alpha. Nat Immunol 2006, 7:1166-1173.
26. Cantrell D.A. GTPases and T cell activation. Immunol Rev 2003, 192:122-130.
27. Goldman F., Hohl R.J., Crabtree J., Lewis-Tibesar K., Koretzky G. Lovastatin inhibits T-cell antigen receptor signaling independent of its effects on ras. Blood 1996, 88:4611-4619.
28. Ghittoni R., Patrussi L., Pirozzi K., et al. Simvastatin inhibits T-cell activation by selectively impairing the function of Ras superfamily GTPases. FASEB J 2005, 19:605-607.